Kinyanjui, S., Mwangi, T., Bull, P., Newbold, C., & Marsh, K. (2004). Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.
Cita Chicago (17th ed.)Kinyanjui, S., T. Mwangi, P. Bull, C. Newbold, i K. Marsh. Protection Against Clinical Malaria by Heterologous Immunoglobulin G Antibodies Against Malaria-infected Erythrocyte Variant Surface Antigens Requires Interaction with Asymptomatic Infections. 2004.
Cita MLA (9th ed.)Kinyanjui, S., et al. Protection Against Clinical Malaria by Heterologous Immunoglobulin G Antibodies Against Malaria-infected Erythrocyte Variant Surface Antigens Requires Interaction with Asymptomatic Infections. 2004.